Osteoclasts in Multiple Myeloma Are Derived from Gr-1+CD11b+Myeloid-Derived Suppressor Cells

Tumor-Induced CD11b+Gr-1+ Myeloid Cells Suppress T Cell Sensitization in Tumor-Draining Lymph Nodes

(2014) S. Watanabe et al.   JOURNAL OF IMMUNOLOGY

Functional Changes in Myeloid-Derived Suppressor Cells (MDSCs) during Tumor Growth: FKBP51 Contributes to the Regulation of the Immunosuppressive Function of MDSCs

(2012) Y.-S. Kim et al.   JOURNAL OF IMMUNOLOGY

miR-223 suppresses differentiation of tumor-induced CD11b+Gr1+myeloid-derived suppressor cells from bone marrow cells

(2011) Qiaofei Liu et al.   INTERNATIONAL JOURNAL OF CANCER

The birth of the osteoclast

(2010) T.J. Chambers   Annals of the New York Academy of Sciences

Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound

(2010) Jonathan R. Green et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine

(2009) M. K. Srivastava et al.   CANCER RESEARCH

A murine model of myeloma that allows genetic manipulation of the host microenvironment

(2009) J. A. Fowler et al.   Disease Models & Mechanisms

Multiple myeloma

(2009) Marc S Raab et al.   LANCET

Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment

(2009) Lauren K. Dunn et al.   PLoS One

First thalidomide clinical trial in multiple myeloma: a decade

(2008) F. van Rhee et al.   BLOOD

The pathogenesis of the bone disease of multiple myeloma

(2008) Claire M. Edwards et al.   BONE

Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation

(2008) Susanne Granholm et al.   JOURNAL OF CELLULAR BIOCHEMISTRY